Sort
15,842 grants matching “pancreatic cancer”
Pancreatic Cancer: Crocetin as a Novel Therapeutic Approach
$246,764Animesh Dhar · University Of Kansas Medical Center · R01 · FY2013 · CA
IAPs As Novel Targets for Cancer Therapy
$246,761Lily Yang · Emory University · R01 · FY2006 · CA
Delineating the myeloid-centric immunosuppressive crosstalk as targets for prognosis and therapy in neuroendocrine tumors
$246,752Christopher M Heaphy · Boston Medical Center · R21 · FY2025 · CA
Mechanisms of pancreatic inflammation in obesity
$246,750Stuart P Weisberg · Columbia University Health Sciences · R03 · FY2025 · DK
Impact of Neutrophil Extracellular Traps (NETs) on the Pancreatic Tumor Microenvironment
$246,714Brian A Boone · West Virginia University · P20 · FY2022 · GM
Project 3: Role of the pancreatic fibroinflammatory microenvironment in obesity-promoted pancreatic cancer
$246,612Stephen J Pandol · University Of California Los Angeles · P01 · FY2023 · CA
Antigen-Specific Monitoring and Therapy in Pancreatic Cancer
$246,538Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2010 · CA
Digestive Diseases Training Program
$246,535David C Whitcomb · University Of Pittsburgh At Pittsburgh · T32 · FY2008 · DK
Molecular Mechanisms of p53 dependent longevity regulation
$246,509Johannes H Bauer · Southern Methodist University · R00 · FY2010 · AG
The Extracellular Matrix in Muscle Atrophy
$246,508Erin E Talbert · University Of Iowa · R00 · FY2022 · AR
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
$246,500Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2023 · CA
Administrative Core
$246,476Dean E. Brenner · University Of Michigan At Ann Arbor · P50 · FY2012 · CA
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
$246,397Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2019 · CA
Core B: Liver Metastasis Resource Core (LMRC)
$246,376Edwin Melencio Posadas · Cedars-Sinai Medical Center · P01 · FY2022 · CA
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer
$246,369Christopher J. Halbrook · University Of California-Irvine · R00 · FY2022 · CA
Apoptosis Inducing to Enhance Tumor Targeting
$246,305Optimum Therapeutics, Llc · R43 · FY2003 · CA
Pharmacologic /Genetic Inhibition of XBP1 as Hypoxia Targeted Therapeutic Strateg
$246,206Albert Koong · Stanford University · P01 · FY2011 · CA
Growth hormone and adult physiology
$246,195Rhonda D. Kineman · University Of Illinois At Chicago · R01 · FY2013 · DK
The Role of Myc in ChREBP-dependent, Glucose-stimulated Gene Expression
$246,163Donald K Scott · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · DK
Assessing pancreatic cancer susceptibility to ceramide-mediated cell death.
$246,123Myles C Cabot · Saint John'S Cancer Institute · R21 · FY2010 · CA
Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP)
$246,000Charles George Eberhart · Johns Hopkins University · R21 · FY2008 · AT
Comparing HTS with Fragment-Based Design for B-Raf and the Ras-Raf Interaction
$245,985Brent R Stockwell · Columbia Univ New York Morningside · R01 · FY2013 · CA
Normal Cellular Prion Protein in Pancreatic Cancer
$245,963Man-Sun M Sy · Case Western Reserve University · R21 · FY2008 · CA
Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma
$245,850Brian Matthew Wolpin · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer
$245,839Luisa Escobar Hoyos · Yale University · R00 · FY2021 · CA